Pancreatic Cancer Research

ResearcherAll India Institute of Medical SciencesActive in the last 2 years

Nidhi Singh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2647-105X; OpenAlex author ID A5100720000. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper

Papers 13

  1. MicroRNA Signatures for Pancreatic Cancer and Chronic Pancreatitis: Expression Profiling by NGS. Co-author DOI 10.1097/mpa.0000000000002297↗
  2. Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00251-023-01318-4↗
  3. Clinical significance of Notch pathway-associated microRNA-107 in pancreatic ductal adenocarcinoma. Co-author DOI 10.2217/fon-2022-0356↗
  4. Association of inflammatory markers with the disease & mutation status in pancreatic cancer. Co-author DOI 10.4103/ijmr.ijmr_2238_18↗
  5. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-021-82266-5↗
  6. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients. Co-author DOI 10.1007/s00432-020-03169-y↗
  7. Progression of Chronic Pancreatitis to Pancreatic Cancer: Is There a Role of Gene Mutations as a Screening Tool? First author DOI 10.1097/mpa.0000000000000975↗
  8. Prognostic significance of plasma matrix metalloprotease-2 in pancreatic cancer patients. Co-author DOI 10.4103/ijmr.ijmr_1348_15↗
  9. Roles of cathepsins in pancreatic cancer. Co-author DOI 10.7869/tg.331↗
  10. High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival. Co-author DOI 10.3109/07357907.2014.1001894↗
  11. Plasma cathepsin L: a prognostic marker for pancreatic cancer. Co-author DOI 10.3748/wjg.v20.i46.17532↗
  12. Prognostic significance of extracellular matrix degrading enzymes-cathepsin L and matrix metalloproteases-2 [MMP-2] in human pancreatic cancer. Co-author DOI 10.3109/07357907.2013.820318↗
  13. p38β MAP kinase as a therapeutic target for pancreatic cancer. Co-author DOI 10.1111/j.1747-0285.2012.01395.x↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anoop Saraya Md · 12 shared papers, 2012–2024 · strength 1.46
  2. Sumaira Rashid · 6 shared papers, 2018–2024 · strength 0.92
  3. Safoora Rashid · 5 shared papers, 2018–2024 · strength 0.69
  4. Imteyaz Ahmad Khan · 3 shared papers, 2021–2024 · strength 0.51
  5. Shikha Roy · 1 shared paper, 2024 · strength 0.18
  6. Dinesh Kumar Gupta · 1 shared paper, 2024 · strength 0.18
  7. Abhay Kumar Singh · 1 shared paper, 2012 · strength 0.03
  8. Sharmistha Dey · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.